The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Observational study of ferric carboxymaltose in France (OncoFer; interim analysis).
Alain Toledano
Honoraria - Vifor Pharma
Research Funding - Vifor Pharma
Elisabeth Luporsi
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
Florian Scotté
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
Jean F. Morere
No relevant relationships to disclose
Philippe Huot-Marchand
No relevant relationships to disclose
Lorraine B. Zakin
Employment or Leadership Position - Vifor Pharma
Lamine Mahi
Employment or Leadership Position - Vifor Pharma
Roland Bugat
Consultant or Advisory Role - Vifor Pharma